Local tumor progression following lipiodol-based targeted chemoembolization of hepatocellular carcinoma: a retrospective comparison of miriplatin and epirubicin

Cancer Management and Research, 04/26/2012

Lipiodol–based targeted transarterial chemoembolization (TACE) using miriplatin had inferior local control rates as compared to epirubicin in patients with hepatocellular carcinoma (HCC).

Print Article Summary